Vistin Pharma ASA
Vistin Pharma ASA: Invitation to Q4 2020 conference call
Oslo, Norway, 12 February 2020
Vistin Pharma ASA will release its fourth quarter 2020 results on Friday 19th of February 2021. Vistin Pharma will host a conference call for all shareholders and interested parties on Friday 19th of February at 08:30 CET. There will be a Q&A session following the management discussion.
The conference call will be held in Norwegian.
The fourth quarter conference call will be available via web and audio through the following access points:
Telephone conference:
Confirmation Code:........ 3067548
International Dial-In:........ +44 (0) 2071 928338
Norway, Oslo:................ +47 21563015
United States, New York: +1 6467413167
Webcast:
https://edge.media-server.com/mmc/p/c6wg4zco
****
For further information, please contact:
Alexander Karlsen
CFO
+47 97053621
alexander.karlsen@vistin.com
About Globenewswire
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
DBV Technologies S.A.5.3.2021 22:31:29 CET | Press release
DBV Technologies to Participate in the H.C. Wainwright Global Life Sciences Conference
Better Collective A/S5.3.2021 19:31:34 CET | Press release
Better Collective – Share buyback program completed
North Media A/S5.3.2021 19:16:13 CET | Press release
Disclosure of managers’ and closely related parties’ transactions with shares in North Media A/S
North Media A/S5.3.2021 19:16:03 CET | Pressemeddelelse
Offentliggørelse af ledende medarbejderes og disses nærtståendes transaktioner med aktier i North Media A/S
Vátryggingafélag Íslands hf.5.3.2021 18:23:11 CET | Press release
VÍS: Viðskipti fruminnherja
Icelandair Group hf.5.3.2021 18:12:01 CET | Press release
Icelandair Group hf.: Candidates for the Board of Directors of Icelandair Group at the AGM on 12 March 2021
TGS5.3.2021 17:53:00 CET | Press release
TGS Share Repurchase
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom